Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne Vulgaris

Completed · Phase 1

Conditions studied: Acne

In brief

Open-Label study designed to assess the safety and plasma PK of tretinoin and relevant metabolites after topical dermal application of IDP-121 lotion.

Key facts

Study ID

NCT02849860

Run by

Bausch Health Americas, Inc.

People needed

20

Starts

2014-02-01

Expected to finish

2016-10-01

Last updated by the study team

2017-12-14

Who can join

Age: 9 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Valeant Site 02 — Austin, Texas, United States
• Valeant Site 01 — College Station, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.